Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
about
Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cellsEarly mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected miceMicroRNAs in the Host Response to Viral Infections of Veterinary ImportanceThe microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesisMicroRNAs in NeurotoxicityApplication of "omics" to prion biomarker discovery.Correlation between polymorphisms in microRNA-regulated genes and cervical cancer susceptibility in a Xinjiang Uygur population.Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques.MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.MicroRNAs: master regulators of ethanol abuse and toxicity?MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration.A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing.A genome-wide survey for prion-regulated miRNAs associated with cholesterol homeostasisDevelopment of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP.A Computational Approach for Predicting Role of Human MicroRNAs in MERS-CoV Genome.MicroRNA and messenger RNA profiling reveals new biomarkers and mechanisms for RDX induced neurotoxicity.Bovine spongiform encephalopathy infection alters endogenous retrovirus expression in distinct brain regions of cynomolgus macaques (Macaca fascicularis)Population differences in microRNA expression and biological implications.MicroRNA networks direct neuronal development and plasticity.Formaldehyde and epigenetic alterations: microRNA changes in the nasal epithelium of nonhuman primates.Synthetic pre-microRNAs reveal dual-strand activity of miR-34a on TNF-α.MiRNA expression profiles in the brains of mice infected with scrapie agents 139A, ME7 and S15.Defining the purity of exosomes required for diagnostic profiling of small RNA suitable for biomarker discovery.MicroRNAs in neurodegenerative diseases and their therapeutic potential.Small RNA drugs for prion disease: a new frontier.Exosomes: the future of biomarkers in medicine.MicroRNA in intervertebral disc degeneration.microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges.microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.miRNAs as biomarkers of neurodegenerative disorders.Analysis of miRNA Signatures in Neurodegenerative Prion Disease.Genetic Variants in MicroRNAs and Their Binding Sites Are Associated with the Risk of Parkinson Disease.Fixed differences in the 3'UTR of buffalo PRNP gene provide binding sites for miRNAs post-transcriptional regulationDifferential Expression of MicroRNAs in Leprosy Skin Lesions.A miRNA expression signature that separates between normal and malignant prostate tissues.Let's make microglia great again in neurodegenerative disorders.Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis.Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases.
P2860
Q21129257-3A5568FB-434C-49B4-99F0-953EDB9A6AA5Q24607278-446CA582-E188-4A5F-9BE4-4468D21B0CFAQ27340506-6E92AD8F-0357-45DE-A195-35BC15881DDAQ28078710-C257F2C3-FDBC-4136-8E6F-0EF57F51FD1BQ28271675-34BB3419-63A3-44FE-A9AA-37CD8C8156C9Q28382954-282EF562-1AE4-435D-83AD-EDC39D05A14FQ33708360-21295031-8D43-44ED-8D40-8C75CF47A3DFQ33761898-6E739594-C7C2-4188-84E2-43F4FD22882AQ33770606-4B6FB692-2248-459C-9605-0032802FEB96Q33961392-20F8C8BC-BBA0-42A2-883A-98F21F5FEE91Q34078032-F2DDBFE3-F2B7-40A3-AAC7-115D441AD3B6Q34101214-08E5E2ED-35C2-4B9E-AD1A-796D338BCDE6Q34123440-6C9C8FDE-7C2F-4E97-9954-FDD5A3007CB8Q34416679-FD4C5126-1859-446A-82BC-CA7CD4B697F8Q34812498-485BE0AF-4873-46EB-94C7-AD1788BFBBFCQ34813357-ADEDFAB4-15D2-4DC3-9AE4-43FC0C37CD8FQ35005163-B6B3E450-E604-4F17-B534-6ADEB900E363Q35155029-4759088F-8EED-45CD-B619-2320784603A8Q35578546-A9706D8A-43C2-48DD-8639-6BECA407A70CQ35644179-EB14FB33-E914-4E86-AA44-F765D048CD1CQ36752327-9313997C-6CD6-42EC-9369-9A1E5FA16DD4Q37400278-347230AB-11AD-45AF-86FA-756FF1BFCB4EQ37489927-54E86CA0-A33C-48B2-BDB7-DA3AC34F5ED9Q37664297-90DADB9C-CD09-4444-AD4F-8632EBB146CCQ37946984-1F57E1BD-7044-4067-8822-CB494AF08E65Q38121120-AEE45C8B-9AD4-452A-90E4-2E7A3F1EE208Q38138606-33D327FA-52CD-4A63-A37A-2894A5D4EB34Q38367405-0FB96405-186C-44D9-9D0F-214303969161Q38375953-73C392AB-B15B-45EA-8646-A22F20E8906AQ38648154-2C9675F7-73CF-489D-9A65-0DD276C9B984Q38911621-F9D977A4-6B5A-4A1B-97A2-B616CD48A06BQ39104808-8E9A04C3-A32F-4461-82EB-E82E9A710970Q40071129-3D62F7C1-33E1-4C6C-8786-1DB5C70F21A1Q40209615-22B6B7D6-82FF-4C34-84E7-817FEB6CBAF4Q41233893-EB7DBBD3-D553-480C-BC11-26FBCA3546E6Q41991878-FD2905CD-958C-4CB8-907B-BC6BA3870949Q42230002-63CD6EDB-5241-426D-97A0-F26B0656CAB9Q46926746-68A47A95-F091-45BE-8A4F-8EFBF84D9BE5Q47550368-3CE9C4C1-9290-4E87-949B-17E0EAB80877Q55004951-80622447-17B0-4ECD-B87E-1AD51816BBFF
P2860
Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
@en
Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
@nl
type
label
Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
@en
Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
@nl
prefLabel
Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
@en
Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
@nl
P2093
P2860
P356
P1476
Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
@en
P2093
Dirk Motzkus
Gerhard Hunsmann
Judith Montag
Reiner Hitt
Walter J Schulz-Schaeffer
P2860
P2888
P356
10.1186/1750-1326-4-36
P577
2009-08-27T00:00:00Z
P5875
P6179
1029059163